251 related articles for article (PubMed ID: 12710102)
1. [Ambulatory criteria of dry powder inhaler selection based on peak inspiratory flow recordings].
Droszcz W; Droscez P
Pneumonol Alergol Pol; 2002; 70(9-10):490-5. PubMed ID: 12710102
[TBL] [Abstract][Full Text] [Related]
2. [The variability of peak inspiratory flow (PIF) on valves imitating dry powder inhalers resistance during asthma and COPD exacerbations].
Grabowski M; Barg W; Chmielowicz B; Kopeć A; Panaszek B
Pneumonol Alergol Pol; 2007; 75(4):324-30. PubMed ID: 18080981
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of peak expiratory flow measurement for selection of dry powder inhalers in asthmatic children].
Emeryk A; Bartkowiak-Emeryk M; Czerwińska-Pawluk I; Postepski J
Pol Merkur Lekarski; 2000 Oct; 9(52):667-70. PubMed ID: 11144053
[TBL] [Abstract][Full Text] [Related]
4. [Selection of a personal dry powder inhaler based on peak inspiratory flow measurements in selected groups of patients with bronchial obstruction].
Kokot M
Pol Merkur Lekarski; 2000 Oct; 9(52):672-6. PubMed ID: 11144054
[TBL] [Abstract][Full Text] [Related]
5. [Easyhaler--ideal dry powder inhaler].
Andrzej E; Małgorzata BE
Pol Merkur Lekarski; 2010 Apr; 28(166):307-10. PubMed ID: 20491343
[TBL] [Abstract][Full Text] [Related]
6. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
[TBL] [Abstract][Full Text] [Related]
7. Dry powder inhalers: advantages and limitations.
Crompton GK
J Aerosol Med; 1991; 4(3):151-6. PubMed ID: 10147676
[TBL] [Abstract][Full Text] [Related]
8. Dry powder inhalers: which factors determine the frequency of handling errors?
Wieshammer S; Dreyhaupt J
Respiration; 2008; 75(1):18-25. PubMed ID: 17911976
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of inspiratory flow for the selection of the inhalation treatment device for asthma and COPD].
Plavec D; Gluncić TJ; Gudelj I; Mise K
Lijec Vjesn; 2012; 134(3-4):84-9. PubMed ID: 22768682
[TBL] [Abstract][Full Text] [Related]
10. The inhalation characteristics of patients when they use different dry powder inhalers.
Azouz W; Chetcuti P; Hosker HS; Saralaya D; Stephenson J; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):35-42. PubMed ID: 24815999
[TBL] [Abstract][Full Text] [Related]
11. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of breath actuated devices in asthmatic children with bronchial obstruction].
Tomalak W; Doniec Z
Wiad Lek; 2006; 59(1-2):61-5. PubMed ID: 16646295
[TBL] [Abstract][Full Text] [Related]
14. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler.
Borgström L; Asking L; Thorsson L
Int J Clin Pract; 2005 Dec; 59(12):1488-95. PubMed ID: 16351685
[TBL] [Abstract][Full Text] [Related]
15. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
Henriet AC; Marchand-Adam S; Mankikian J; Diot P
Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
Harb HS; Laz NI; Rabea H; Abdelrahim MEA
Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
[TBL] [Abstract][Full Text] [Related]
17. Use of dry powder inhalers in COPD.
Wilson DS; Gillion MS; Rees PJ
Int J Clin Pract; 2007 Dec; 61(12):2005-8. PubMed ID: 17997806
[TBL] [Abstract][Full Text] [Related]
18. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of Turbuhaler dry powder inhaler in Japanese asthma--measurement of peak inspiratory flow when using Turbuhaler].
Kaneko N; Narushima M; Tanaka K; Suzuki H
Arerugi; 1996 Jul; 45(7):649-54. PubMed ID: 8831169
[TBL] [Abstract][Full Text] [Related]
20. Inspiratory flow rates at different levels of resistance in elderly COPD patients.
Janssens W; VandenBrande P; Hardeman E; De Langhe E; Philps T; Troosters T; Decramer M
Eur Respir J; 2008 Jan; 31(1):78-83. PubMed ID: 17898020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
